Ligand Pharmaceuticals Inc (LGND)
CapEx to Revenue
0.04%
Quarterly · Period ending:
LGND CapEx to Revenue
Latest reported0.04%period ending
Latest reported0.04%period ending
LGND Quarterly CapEx/Revenue (8.70% → 0.04%)
Latest values, visible window
High-resolution chart · PNG
LGND capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 2.7274% | |
| 5.066% | |
| 0.353% | |
| 1.5079% | |
| 4.9021% | |
| 2.8023% | |
| 301.6129% | |
| 6.1224% | |
| 11.9048% | |
| 4.8544% | |
| 30.2326% | |
| 5.1282% | |
| 11.3636% | |
| 15.6863% | |
| 2.7523% | |
| 1.9608% | |
| 34.3434% | |
| 1.0204% | |
| 1.0417% | |
| 1.9802% | |
| 1.1765% | |
| 4.5455% | |
| 0% | |
| 0% | |
| 0% | |
| 6.5217% | |
| 6.25% | |
| 2.7027% | |
| 0% | |
| 8.6957% |